Sort   by:  
 Page size 
UnknownMagnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.
Not available
S-EPMC3392187 | biostudies-literature
UnknownPrevention of HIV-1 infection with early antiretroviral therapy.
Not available
S-EPMC3200068 | biostudies-literature
UnknownAsynchrony among local communities stabilises ecosystem function of metacommunities.
Not available
S-EPMC6849522 | biostudies-literature
UnknownEffects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC9792409 | biostudies-literature
UnknownCombination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
Not available
S-EPMC7068822 | biostudies-literature
UnknownPerformance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.
Not available
S-EPMC11565374 | biostudies-literature
UnknownTreatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.
Not available
S-EPMC10551026 | biostudies-literature
UnknownEffectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
Not available
S-EPMC9113447 | biostudies-literature
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931 | biostudies-literature
Sort   by:  
 Page size